## Abstract Dynamic contrast‐enhanced MRI (DCE‐MRI) is frequently used to provide response biomarkers in clinical trials of novel cancer therapeutics but assessment of their physiological accuracy is difficult. DCE‐CT provides an independent probe of similar pharmacokinetic processes and may be mod
COMPARISON BETWEEN PERFUSION-CT AND DYNAMIC CONTRAST-ENHANCED MRI IN RECTAL CANCER
✍ Scribed by Kierkels, R.; Backes, W.; Janssen, M.; Buijsen, J.; Beets-Tan, R.; Lambin, P.; Lammering, G.; Oellers, M.; Aerts, H.
- Book ID
- 123224453
- Publisher
- Elsevier Science
- Year
- 2009
- Tongue
- English
- Weight
- 87 KB
- Volume
- 92
- Category
- Article
- ISSN
- 0167-8140
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract Mycosis fungoides is a malignant, cutaneous lymphoma of T‐helper (TH or CD4+) cells. At presentation, the disease is usually limited to the skin, with lesions that resemble eczema or psoriasis. Neurologic involvement is uncommon. This case demonstrates the conventional MRI and dynamic c
## Abstract Cervical tumors of 38 cervix cancer patients were scanned by __T__~1~‐weighted dynamic contrast enhanced (DCE) MRI and then by DCE‐CT on the same day. Gadodiamide and iohexol were respectively used as the low‐molecular‐weight contrast agent in DCE‐MRI and DCE‐CT. Under an extended Tofts